Literature DB >> 17909905

Epithelioid sarcoma: prognostic factors and survival in a series of patients treated at a single institution.

Dario Baratti1, Elisabetta Pennacchioli, Paolo G Casali, Rossella Bertulli, Laura Lozza, Patrizia Olmi, Paola Collini, Stefano Radaelli, Marco Fiore, Alessandro Gronchi.   

Abstract

BACKGROUND: Epithelioid sarcoma (ES) is a rare subtype of soft-tissue sarcoma of unknown histogenesis. Typically, it occurs superficially as single/multiple nodules (nodular ES), or in deeper tissues as a mass. The correlation between initial presentation and clinical outcome was investigated.
METHODS: Fifty-four consecutive patients surgically treated at a single referral center were retrospectively reviewed. Thirty-six patients presented with a primary and 18 with a recurrent tumor. Potential prognostic clinicopathological variables, including macroscopic features at first presentation, were tested by univariable and multivariable analysis with respect to overall (OS), metastasis-free (MFS), and local recurrence-free survival (LRFS).
RESULTS: The 10-year OS was 61.8% for the whole series. Thirty patients relapsed; in detail, local and distant failure occurred in 14 (25.9%) and 24 (44.4%) patients, respectively. The lymph node involvement rate was 16/54 (29.6%). In both the whole series and the subset of patient with primary ES, single localized tumor correlated with increased OS at multivariable analysis; occurrence of nodal involvement during postoperative follow-up correlated to worse OS and MFS. Nodular ES was an independent predictor of worse LRFS. In univariable analysis, nodular ES was associated with smaller tumor size, distal limb locations, earlier classification of malignant tumor (TNM) stage, and higher amputation rate. A statistical difference in the pattern of failure between nodular and mass ES was found.
CONCLUSIONS: Primary tumor macroscopic features seem to correlate to different local aggressiveness and failure patterns. Better prognosis is associated with single localized disease stage and no occurrence of locoregional spread.

Entities:  

Mesh:

Year:  2007        PMID: 17909905     DOI: 10.1245/s10434-007-9628-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  21 in total

Review 1.  Epithelioid sarcoma in a child presenting as a submandibular mass.

Authors:  S Al-Salam; M Al Ashari
Journal:  Afr Health Sci       Date:  2010-12       Impact factor: 0.927

2.  Epithelioid Sarcoma in the Cervical Spine: A Case Report.

Authors:  Chungnam Lee; Woo Jin Choe; Nara Kim
Journal:  Korean J Spine       Date:  2015-09-30

3.  Synovial Sarcoma Is Not Associated With a Higher Risk of Lymph Node Metastasis Compared With Other Soft Tissue Sarcomas.

Authors:  Andrew J Jacobs; Carol D Morris; Adam S Levin
Journal:  Clin Orthop Relat Res       Date:  2018-03       Impact factor: 4.176

4.  Epithelioid sarcoma and unclassified sarcoma with epithelioid features: clinicopathological variables, molecular markers, and a new experimental model.

Authors:  Aniket Sakharpe; Guy Lahat; Taher Gulamhusein; Ping Liu; Svetlana Bolshakov; Theresa Nguyen; Pingyu Zhang; Roman Belousov; Eric Young; Xianbiao Xie; Priya Rao; Jason L Hornick; Alexander J Lazar; Raphael E Pollock; Dina Lev
Journal:  Oncologist       Date:  2011-02-28

5.  Clinical outcomes of patients with epithelioid sarcomas: impact and management of nodal metastasis.

Authors:  Hidetatsu Outani; Yoshinori Imura; Takaaki Tanaka; Satoshi Takenaka; Kazuya Oshima; Kenichiro Hamada; Shigeki Kakunaga; Susumu Joyama; Norifumi Naka; Ikuo Kudawara; Takafumi Ueda; Nobuhito Araki; Hideki Yoshikawa
Journal:  Int J Clin Oncol       Date:  2017-08-10       Impact factor: 3.402

6.  Recurrent epithelioid sarcoma in the thoracic spine successfully treated with multilevel total en bloc spondylectomy.

Authors:  Pongsthorn Chanplakorn; Niramol Chanplakorn; Atcharaporn Pongtippan; Suphaneewan Jaovisidha; Wichien Laohacharoensombat
Journal:  Eur Spine J       Date:  2011-02-18       Impact factor: 3.134

7.  Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trials.

Authors:  Sheri L Spunt; Nadine Francotte; Gian Luca De Salvo; Yueh-Yun Chi; Ilaria Zanetti; Andrea Hayes-Jordan; Simon C Kao; Daniel Orbach; Bernadette Brennan; Aaron R Weiss; Max M van Noesel; Lynn Million; Rita Alaggio; David M Parham; Anna Kelsey; R Lor Randall; M Beth McCarville; Gianni Bisogno; Douglas S Hawkins; Andrea Ferrari
Journal:  Eur J Cancer       Date:  2019-04-05       Impact factor: 9.162

8.  Prognostic factors for survival in patients with epithelioid sarcoma: 441 cases from the SEER database.

Authors:  Muhammad Umar Jawad; Jason Extein; Elijah S Min; Sean P Scully
Journal:  Clin Orthop Relat Res       Date:  2009-02-18       Impact factor: 4.176

Review 9.  Epithelioid Sarcoma: Opportunities for Biology-Driven Targeted Therapy.

Authors:  Jonathan Noujaim; Khin Thway; Zia Bajwa; Ayeza Bajwa; Robert G Maki; Robin L Jones; Charles Keller
Journal:  Front Oncol       Date:  2015-08-17       Impact factor: 6.244

10.  Epithelioid sarcoma: one institution's experience with a rare sarcoma.

Authors:  Angela A Guzzetta; Elizabeth A Montgomery; Heather Lyu; Craig M Hooker; Christian F Meyer; David M Loeb; Deborah Frassica; Kristy L Weber; Nita Ahuja
Journal:  J Surg Res       Date:  2012-05-01       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.